LISATA THERAPEUTICS, INC. Logo

LISATA THERAPEUTICS, INC.

Develops therapies to enhance anti-cancer drug delivery to solid tumors.

LSTA | US

Overview

Corporate Details

ISIN(s):
US1280583022 (+1 more)
LEI:
Country:
United States of America
Address:
110 ALLEN ROAD, 7920 BASKING RIDGE

Description

Lisata Therapeutics is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for advanced solid tumors and other major diseases. The company's core technology is the proprietary CendR Platform®, designed to enhance the targeted, tissue-penetrating delivery of anti-cancer drugs to solid tumors. The platform also aims to target non-cancerous, immunosuppressive cells within the tumor microenvironment, seeking to improve the efficacy of a patient's immune system and immunotherapies in fighting cancer.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-06 17:16
10-Q
English 1.9 MB
2025-11-06 17:10
8-K
English 17.4 MB
2025-10-14 18:02
8-K
English 15.4 MB
2025-10-08 17:12
8-K
English 58.4 KB
2025-08-07 18:13
10-Q
English 26.4 MB
2025-08-07 18:09
8-K
English 15.9 MB
2025-07-15 10:00
8-K
English 759.7 KB
2025-06-26 10:38
8-K
English 17.8 MB
2025-06-17 11:13
8-K
English 14.7 MB
2025-06-13 18:02
8-K
English 24.5 MB
2025-06-10 18:03
8-K
English 57.7 KB
2025-05-08 18:14
10-Q
English 2.1 MB
2025-05-08 18:07
8-K
English 12.7 MB
2025-04-25 18:12
DEFA14A
English 12.6 MB
2025-04-25 18:10
DEF 14A
English 16.8 MB

Automate Your Workflow. Get a real-time feed of all LISATA THERAPEUTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for LISATA THERAPEUTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for LISATA THERAPEUTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Acurx Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing a new class of antibiotics for priority pathogens.
United States of America
ACXP
Adaptimmune Therapeutics PLC Logo
Commercial-stage biopharma developing TCR T-cell therapies for solid tumors.
United States of America
ADAP
ADBIOTECH Co.,Ltd. Logo
Develops IgY-based immune antibodies as alternatives to vaccines and antibiotics.
South Korea
179530
ADC Therapeutics SA Logo
Commercial-stage biotech developing antibody-drug conjugates for cancer therapy.
United States of America
ADCT
Addex Therapeutics Ltd. Logo
Clinical-stage biopharma developing allosteric modulators for neurological disorders.
Switzerland
ADXN
ADIAL PHARMACEUTICALS, INC. Logo
A clinical-stage biopharma developing genetically targeted therapies for addiction.
United States of America
ADIL
Adicet Bio, Inc. Logo
Develops allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America
ACET
Adlai Nortye Ltd. Logo
A clinical-stage biopharma firm developing cancer immunotherapies and RAS-targeting drugs.
United States of America
ANL
ADMA BIOLOGICS, INC. Logo
Biopharmaceutical company that develops and manufactures plasma-derived biologics.
United States of America
ADMA
Adverum Biotechnologies, Inc. Logo
A clinical-stage company developing gene therapies for ocular diseases.
United States of America
ADVM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.